Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care
Open Access
- 1 July 2020
- journal article
- editorial
- Published by Future Medicine Ltd in Future Oncology
- Vol. 16 (20), 1413-1416
- https://doi.org/10.2217/fon-2020-0364
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemicThe Lancet Oncology, 2020
- Cancer care in the time of COVID-19Published by Elsevier BV ,2020
- Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemicNature Reviews Clinical Oncology, 2020
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common GoalJournal of the National Comprehensive Cancer Network, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.2014